Introduction
in understanding the signalling pathways acting downstream of the proteins encoded by these oncogenes, in Many mammalian cell types are dependent on adhesion particular the Ras proteins. Ras is now known to be able to the extracellular matrix for their continued survival.
to interact directly with a number of families of target Upon detachment from the matrix, endothelial (Meredith enzymes, or putative effectors (Marshall, 1996) . The best et al., 1993) and epithelial cells (Frisch and Francis, 1994) characterized of these are the Raf proteins, which are protoenter into programmed cell death; this cell detachmentoncogene-encoded serine/threonine kinases that control the induced apoptosis has been referred to as 'anoikis', from MAP kinase, or ERK, signalling pathway and are activated the Greek for homelessness (Frisch and Francis, 1994) .
upon interaction with Ras . The Raf/MAP This mechanism ensures that these types of cells do not kinase pathway is essential for fibroblast proliferation normally survive in the absence of the correct interaction (Cowley et al., 1994) and is likely to be important in the with extracellular matrix proteins and therefore are unable transformation of fibroblasts and other cell types by ras to proliferate in inappropriate sites or to survive in the oncogenes. In addition to Raf, a number of other possible absence of attachment, for example in the bloodstream.
targets for Ras are known: the GTPase-activating proteins, Some adherent cell types with a specialized tissue invasive p120 GAP , Gap1 and neurofibromin, all of which interact function, such as some fibroblasts, do not undergo anoikis, with Ras·GTP but not Ras·GDP, could possibly have some although they do become quiescent in the absence of function downstream of Ras in addition to their negative contact with the matrix (Folkman and Moscona, 1978; Ben-Ze'ev et al., 1980) . regulatory function (Schweighoffer et al., 1992; McGlade et al., 1993) . Ral-GDS, a family of exchange factors for cells. All the Ras effector site mutants showed wild-type morphology, with the exception of V12 C40 Ras, which the Ras-related Ral proteins, have been found to interact with activated Ras in the yeast two-hybrid system (Hofer had a dispersed spindly morphology very similar to V12 Ras-or v-Src-transformed MDCK cells. This morphology et al., 1994; Kikuchi et al., 1994; Spaargaren and Bischoff, 1994) . Activated Ras is able to regulate the activity of was also indistinguishable from that of cells expressing activated PI 3-kinase. Cells expressing activated Raf still Ral-GDS and hence Ral : the function of Ral is not well understood, but it has been implicated grew in islands, but showed a slightly more spindly shape than wild-type cells. Cells expressing activated Rac in the control of phospholipase D (Jiang et al., 1995) . Furthermore, phosphoinositide 3-OH kinase appeared to be similar to activated PI 3-kinase-or Rasexpressing cells, while activated PKB/Akt-expressing cells has been shown to interact with GTP-bound Ras, resulting in stimulation of the lipid kinase activity (Kodaki et al., had a morphology similar to wild-type (data not shown).
The ability of these cell lines to undergo apoptosis upon 1994; Rodriguez-Viciana et al., 1994 , 1996 . In addition to these Ras effectors, a number of other mammalian detachment from the extracellular matrix was measured. Cells were grown on plastic dishes in serum-containing proteins have been described which interact with Ras in a GTP-dependent manner but for which further confirmamedium before being removed from the dish, held in suspension in 10% fetal calf serum (FCS) for 8-12 h, tion of their role in Ras signalling is not yet available.
In this report, we have set out to study the mechanism and the extent of apoptosis determined by measuring characteristic DNA laddering (Figure 2A ), the number of by which an activated ras oncogene protects the MDCK epithelial cell line from programmed cell death on removal cells that are capable of surviving when replated ( Figure  2B ) or by enzyme-linked immunosorbent assay (ELISA) from the extracellular matrix. We show that the Raf/MAP kinase pathway is not involved, but that the PI 3-kinase assay for cytoplasmic histone-associated DNA fragments ( Figure 2C ). Parental cells, and clones expressing inactive pathway is both necessary and sufficient for the Ras protection of epithelial cells from anoikis, and also from V12 A38 Ras, were highly susceptible to apoptosis following removal from the extracellular matrix, as were cells radiation-induced apoptosis. The serine/threonine kinase known as protein kinase B, Akt or Rac kinase (Bellacosa expressing activated Raf, and Ras mutants that stimulate only Raf (V12 E38 and V12 S35, data not shown) or Ralet al., 1991; Coffer and Woodgett, 1991; Jones et al., 1991) , referred to here as PKB/Akt, but not the GTPase GDS (V12 G37). All MDCK clones expressing V12 Ras or v-Src were almost completely protected from apoptosis Rac or p70 S6K , is implicated downstream of PI 3-kinase in this survival pathway. In normal epithelial cells, detachfollowing detachment. Clones expressing activated PI-3 kinase were also very highly protected, as were cells ment from matrix leads to a rapid decrease in the levels of the PI 3-kinase products and PKB/Akt activity, while expressing V12 C40 Ras, which activates PI 3-kinase only. It therefore appears that the ability of Ras to protect reattachment causes rapid elevation of these lipids and kinase activity: a basal level of PI 3-kinase and PKB/Akt these epithelial cells from anoikis is mediated through the PI 3-kinase, and not the Raf, pathway. In order to investiactivity is normally maintained by matrix attachment which is essential for avoidance of programmed cell death.
gate which effector pathway downstream of PI 3-kinase is being used in the protection from anoikis, assays were In Ras-transformed cells, the levels of the PI 3-kinase product lipids remain high even in suspension, and Akt/ performed on MDCK cell clones expressing V12 Rac or activated PKB/Akt. V12 Rac did not protect the cells PKB is constitutively activated. A novel signalling pathway is therefore being activated by Ras, acting through from anoikis, but activated PKB/Akt gave comparable protection to activated PI 3-kinase or Ras. Furthermore, PI 3-kinase and PKB/Akt to protect Ras-transformed epithelial cells from programmed cell death initiated by rapamycin (Price et al., 1992) , which indirectly inhibits p70 S6K , was unable to induce apoptosis of adherent MDCK disengagement of integrins. cells, whereas the stable PI 3-kinase inhibitor LY294002 (Thelen et al., 1994; Vlahos et al., 1994) 
does (Figure

Results
2C). Therefore PKB/Akt is likely to be involved in the protection from anoikis provided by PI 3-kinase, but Rac Ras and PI 3-kinase protect MDCK cells from apoptosis in suspension culture and p70 S6K are not important in this response. MDCK cells were transfected with constructs expressing activated forms of H-Ras (V12 Ras), Src (v-Src), Raf Inhibition of PI 3-kinase or PKB/Akt reverses protection from anoikis (Raf-CAAX) (Leevers et al., 1994) , PI 3-kinase (p110*), Rac (V12 Rac) and PKB/Akt (gag-PKB) (Burgering and
The effect of inhibition of PI 3-kinase activity on the ability of activated Ras, Src and PI 3-kinase to protect Coffer, 1995) . A number of partial loss-of-function mutant Ras proteins were also expressed that distinguish between MDCK cells from apoptosis on detachment from matrix was studied. As shown in Figure 3A and B, LY294002 the various effector pathways downstream of Ras (Marshall, 1996) : V12 S35 Ras and negated the protection from anoikis bestowed by V12 Ras, V12 C40 Ras, Src and PI 3-kinase, but did not V12 E38 Ras (Krengel et al., 1990) activate only the Raf pathway, V12 G37 Ras interacts only reverse the protection due to activated Akt/PKB. PI 3-kinase activity is therefore required for activated Ras, with Ral-GDS, V12 C40 Ras (Joneson et al., 1996) activates only the PI 3-kinase pathway (Rodriguez-Viciana Src and p110 to protect epithelial cells from anoikis, but activation of Akt/PKB can provide the entire survival et al., 1997), while V12 A38 Ras is totally inactive. The morphology of representative clones of these cells is signal generated by PI 3-kinase. PI 3-kinase inhibitory drugs could not completely reverse V12 Ras protection shown in Figure 1 . Wild-type MDCK cells had a typical epithelioid morphology, growing in islands of compact from anoikis: this is probably due to the inability of these drugs to completely reverse V12 Ras-induced elevation growing in serum-containing medium as an adherent monolayer. As shown in Figure 4 , V12 Ras strongly of phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) levels in cells (Rodriguez-Viciana et al., 1997) and PKB/Akt protects from UV radiation-induced apoptosis, as do activated PI 3-kinase, v-Src and V12 C40 Ras, all to a stimulation (data not shown), possibly due to Ras interaction with drug-resistant PI 3-kinase isoforms (Virbasius slightly lesser extent. V12 G37 Ras fails to protect, while Raf-CAAX shows only a low, but statistically significant, et al., 1996) . To assess whether PKB/Akt function was required for normal survival of epithelial cells on matrix, level of protection. PI 3-kinase is thus important in protecting cells from more than one type of programmed a deletion mutant (Datta et al., 1995) of PKB/Akt (AHAkt, retaining only residues 1-147, the regulatory domain cell death, although somewhat different mechanisms may be involved in each case. The weak protection by Rafof PKB/Akt) which has dominant-negative function was transiently expressed in normal MDCK cells. As shown CAAX from UV irradiation-induced apoptosis might possibly be mediated by the autocrine growth factors known in Figure 3C , expression of this construct induced programmed cell death in adherent cells growing normally to be produced by cells expressing activated Raf (McCarthy et al., 1995) , which are capable of activating in serum. The ability of this AH-Akt construct to act as a dominant-negative in terms of the regulation of wild-PI 3-kinase and PKB/Akt. As shown in Figure 6D , growth factors have a greatly reduced ability to activate PKB/Akt type PKB/Akt was tested by co-transfecting it along with tagged wild-type PKB/Akt into MDCK cells under the via PI 3-kinase in cells in suspension (as in the anoikis assay) compared with on the dish (as in the UV-induced same conditions as in Figure 3C . Tagged PKB/Akt was immunoprecipitated from the transfected cells and assayed apoptosis assay); conditioned medium from activated Rasor Raf-expressing cells, and indeed added growth factors for kinase activity towards histone 2B as described in Materials and methods. Four μg of AH-Akt vector comor serum, will not protect normal MDCK cells from anoikis (data not shown). pletely abolished the ability of hepatocyte growth factor/ scatter factor to induce activation of tagged PKB/Akt (1 μg of vector), which was~2-fold in the absence of the Attachment of cells to matrix induces elevation of 3Ј phosphorylated phosphoinositides dominant negative. The unstimulated basal kinase activity of PKB/Akt (corrected for expression level) was reduced
The data from Figures 2 and 3 suggest that attachment of MDCK cells to the extracellular matrix may stimulate the by Ͼ50% by AH-Akt under these conditions. activity of PI 3-kinases leading to the production of elevated levels of PIP 3 and phosphatidylinositol 3,4-Activated PI 3-kinase blocks DNA damage-induced apoptosis diphosphate [PI(3,4)P 2 ] which then act to protect the cells from apoptosis by stimulating PKB/Akt, possibly by direct In order to investigate whether activation of PI 3-kinase was able to suppress other forms of apoptosis in MDCK binding to its pleckstrin homology domain (Franke et al., 1995; James et al., 1996) . In this model, removal of cells cells, the various MDCK cell lines were tested for their sensitivity to UV irradiation-induced apoptosis when from matrix would be expected to result in a decrease in PIP 3 levels, as would treatment of adherent cells with PI presence of 10% FCS show very similar changes in PIP 3 and PI(3,4)P 2 levels following detachment and reattach-3-kinase inhibitors, both of which trigger apoptosis. In order to test this hypothesis, the levels of PIP 3 and ment. Cycling cells in the presence of serum do not show significantly elevated levels of 3Ј phosphorylated PI(3,4)P 2 were compared in cells in suspension versus adherent cells. As shown in Figure 5A and B, parental phosphoinositides relative to quiescent cells in the absence of serum. Although acute treatment with serum does cause MDCK cells growing on dishes in serum-free medium have levels of PIP 3 and PI(3,4)P 2 that are 3-to 5-fold moderate elevation of these lipids, the effect is very transient, rapidly returning to basal levels (data not shown). higher than those in cells which have been in suspension for 2 h. Upon replating cells on collagen, there is a rapid These effects on PIP 3 and PI(3,4)P 2 levels are not due to global changes in phospholipid metabolism since in increase in PIP 3 and PI(3,4)P 2 to levels similar to those of the original adherent cells. Cells growing in the continuous this cell type the levels of PI(4,5)P 2 are not altered on detachment ( Figure 5C ). The fact that PI 3-kinase lipid product levels are elevated by matrix attachment alone in the absence of serum factors indicates that attachment of epithelial cells to extracellular matrix is sufficient for activation of PI 3-kinase. In the case of p110-CAAX-and V12 Ras-expressing cells, the level of PIP 3 in adherent cells in serum-free medium was markedly higher than in parental cells ( Figure 5D ). Upon suspension, the levels of PIP 3 and PI(3,4)P 2 drop only slightly in p110-CAAX-and V12 Ras-expressing cells, remaining well above those in adherent parental MDCK cells. v-Src-and V12 C40 Rasexpressing cells in suspension also maintain levels of PIP 3 that are above that of adherent wild-type cells. The ability of cells to resist anoikis thus correlates with their ability to maintain levels of PI 3-kinase activity in suspension that are at least as great as in normal adherent cells.
Attachment induces activation of PKB/Akt
In addition to studying lipid levels, the activation state of the known downstream protein kinase targets of PI 3-kinase, p70 S6K and PKB/Akt, was also measured (Burgering and Coffer, 1995; Franke et al., 1995; Weng et al., 1995) . p70 S6K shows elevated activity in V12 Ras-, V12 C40 Ras-, v-Src-or p110-CAAX-expressing cells in suspension, while normal MDCK cells and those expressing Raf-CAAX or V12 G37 Ras show no p70 S6K activity under these conditions ( Figure 6A ). Endogenous Ras function previously has been reported not to be necessary for activation of p70 S6K by growth factors (Ming et al., 1994) : these data show that expression of V12 Ras is, however, sufficient to stimulate this kinase, both in adherent and suspended cells. By contrast, only V12 Rasand Raf-CAAX-expressing cells show high Erk2 MAP kinase activity in suspension. In addition, attachment of normal MDCK cells to collagen-coated plates is found to cause activation of Erk2 and p70 S6K , even in the absence ment to collagen it increases by 10-fold ( Figure 6C and of serum factors ( Figure 6B ). The Erk2 activation seen D). PKB/Akt is constitutively very active in V12 Ras-, here is considerably stronger than the very weak activation p110-CAAX-or V12 C40 Ras-expressing cells, both when reported by Frisch et al. (1996) : the reason for this is not adherent ( Figure 6C ) and in suspension (data not shown) clear. The activation of p70 S6K found here is sensitive to but not in Raf-CAAX-or V12 G37 Ras-expressing cells. inhibition by the PI 3-kinase inhibitor wortmannin, and Thus PKB/Akt activity, and also that of p70 S6K , closely also by LY294002 (data not shown). The activation state reflects the levels of PIP 3 and PI(3,4)P 2 , with matrix of PKB/Akt was also studied: on detachment, cellular attachment alone providing a significant level of PI PKB/Akt activity drops by 3-to 5-fold, and on reattach-3-kinase, PKB/Akt and p70 S6K activity. Serum factors are unable to maintain high levels of any of these three activities in the absence of integrin engagement. In response to specific growth factors, saturating concentrations of epidermal growth factor (EGF) will give a weak acute stimulation of PKB/Akt in cells in suspension, to a similar extent to the chronic stimulation seen due to adhesion alone in the absence of growth factors ( Figure  6D ). Presumably, adhesion in the absence of growth factors can protect from apoptosis because it causes long lasting activation of PKB/Akt, whereas the stimulation of this kinase by growth factor in the absence of adhesion is only transient. However, adhesion and EGF together give a strongly synergistic activation of PKB/Akt. V12 Ras or p110-CAAX keep both 3Ј phosphorylated phosphoinositide lipid levels and p70 S6K and PKB/Akt activity elevated even in the absence of attachment.
In common with parental MDCK cells, V12 Ras-and p110-CAAX-expressing cells show no tyrosine phosphorylation of p125 FAK when in suspension (data not shown), suggesting that the protection from apoptosis of these clones is not mediated by constitutive activation of p125 FAK . However, in MDCK cells growing on the dish, or adhering to collagen, complexes of p125 FAK with p85, the regulatory subunit of PI 3-kinase, can be detected; these disappear on placing the cells in suspension (data not shown). Similar complexes have been observed in other cell types (Chen and Guan, 1994) . It is possible that adhesion-induced activation of PI 3-kinase activity is at least in part mediated by this interaction, and possibly also by Ras which is activated on integrin engagement (Kapron-Bras et al., 1993; Clark and Hynes, 1996) . were seen for all constructs tested in at least three distinct clones. (B) LY294002 reverses Ras and PI 3-kinase but not activated PKB protection from anoikis. DNA fragmentation was quantified by ELISA after cells were kept in suspension for 8 h in the presence of 20 μM LY294002 (50 μM V12 Ras). Comparison is made with wild-type cells maintained in suspension without LY294002. Data are mean Ϯ SEM from three to five separate estimations with at least two distinct clones for each cell type. (C) Dominant-negative PKB/Akt induces apoptosis in MDCK cells. MDCK were co-transfected with pCMV βgal and pSG5 AH-Akt (dominant-negative Akt), pSG5 V12Ras or empty vector. At 24 h after transfection, cells were fixed and stained for β-galactosidase activity. Positively stained cells were scored as normal or apoptotic on the basis of cellular morphology. Data are mean Ϯ SE of three separate estimations. For comparison, treatment of MDCK with the PI 3-kinase inhibitor LY294002 for a similar period results in the apoptosis of 60% of cells. present report shows for the first time that activation of PI 3-kinase is sufficient to protect cells from apoptotic death.
Activated Ras has variable effects on apoptosis in different cell types, although most commonly it suppresses programmed cell death induced by a variety of agents (Lin et al., 1995) . In MDCK cells, activated Ras uses a PI 3-kinase-mediated mechanism to protect from at least two forms of apoptosis, induced either by detachment from matrix or by UV radiation-induced DNA damage. Activated Ras probably protects by directly stimulating PI 3-kinase: it is unlikely that the PI 3-kinase involvement downstream of Ras is through a mechanism involving autocrine production of growth factors since the presence of 10% serum in the medium in which cells are suspended is unable to rescue them from programmed cell death. Conversely, adherent MDCK cells are able to survive in subunit of PI 3-kinase and activates it (Kodaki et al., 1994; Rodriguez-Viciana et al., 1994 , 1996 : activated Discussion mutants of Ras acting alone can stimulate PI 3-kinase activity in this way, and endogenous normal Ras can The data presented here support the following model of integrin signalling to the apoptotic machinery in untranscontribute to PI 3-kinase activation in synergy with other pathways, particularly those involving the interaction of formed epithelial cells. Upon engagement of integrins by extracellular matrix proteins, PI 3-kinase becomes phosphoproteins with the SH2 domains of p85 (Klinghofer et al., 1996; Rodriguez-Viciana et al., 1996) . The various constitutively activated to a significant level, independently of signals from serum factors. The PI 3-kinase lipid partial loss-of-function effector mutants of Ras used in this study have been described in detail elsewhere (Rodriguezproducts provide a protective signal acting through PKB/ Akt which blocks entry into apoptosis; PI 3-kinase, Viciana et al., 1997) : they define a number of effector pathways that Ras can activate. Although the various although not PKB/Akt, previously has been reported to be required for cell survival in other systems (Yao and mutants are 3-to 10-fold less efficient than normal activated Ras in switching on their targets, under conditions Cooper, 1995 Cooper, , 1996 . When epithelial cells are detached from the matrix, PI 3-kinase and PKB/Akt become inof modest overexpression such as here they are able to give close to maximal activation of the downstream active, even in the presence of serum factors, and an apoptosis pathway is engaged. Commitment to apoptosis pathways that they engage. While we cannot rule out the possibility that effectors other than PI 3-kinase contribute is blocked if PI 3-kinase activity is stimulated in these suspended cells by expression of p110-CAAX or activated slightly to the Ras protection from anoikis, our data would indicate that Raf and Ral-GDS play no significant part in Ras, which directly binds and stimulates p110 (Kotani et al., 1994; Rodriguez-Viciana et al., 1994 , 1996  this pathway. The mechanism whereby integrin engagement leads to Klinghofer et al., 1996) , or if activated PKB/Akt is expressed. Thus PI 3-kinase and PKB/Akt play a critical PI 3-kinase activation in normal epithelial cells is not known. At present we do not know whether endogenous role in sensing the adhesion status of the cell and promoting its survival. The ability of Ras in cells in suspension to normal Ras plays a role in this pathway: it is unknown whether Ras is activated in response to integrin engageactivate PI 3-kinase, and hence PKB/Akt, explains the survival of ras oncogene-expressing cells in the absence ment in epithelial cells, although it may well be since integrin engagement alone causes activation of Erk2 in of adhesion to the extracellular matrix, one of the principal hallmarks of malignant transformation.
these cells (Figure 6 ). In other cell types, dominantnegative Ras has been reported to block integrin-induced PI 3-kinase previously has been implicated in growth factor protection from apoptosis in PC12 cells (Yao and Erk2 activation in fibroblasts (Clark and Hynes, 1996) and integrin engagement has been shown to increase Cooper, 1995) and in fibroblasts (Yao and Cooper, 1996) . The PI 3-kinase inhibitors wortmannin and LY294002
Ras·GTP levels in lymphocytes (Kapron-Bras et al., 1993) . Another possible component of this pathway is p125 FAK : induce apoptosis in PC12 cells, and the ability of the platelet-derived growth factor (PDGF) receptor to protect this focal adhesion kinase has been found to associate with the SH2 domains of p85 (Chen and Guan, 1994) , so these cells from apoptosis relies on the presence of Tyr740, which when phosphorylated is a binding site for the SH2 it may contribute to the constitutive activation of PI 3-kinase during adherent growth when p125 FAK is condomains of the p85 regulatory subunit of PI 3-kinase. In addition, the use of these inhibitors has implicated PI tinuously tyrosine phosphorylated and capable of binding p85. Since serum factors are not required, it is likely that 3-kinase in protecting some haemopoietic cells from apoptosis (Scheid et al., 1995; Minshall et al., 1996) . The this interaction by itself is enough to maintain a level of PI 3-kinase activity sufficient to protect epithelial cells From indirect (see Figure 3 ) and direct (RodriguezViciana et al., 1997 ; A.Khwaja, P.Rodriguez-Viciana and from anoikis. The decrease in PIP 3 and PI(3,4)P 2 levels on detachment may be due either to loss of p125 FAK J.Downward, unpublished data) observations, there are indications that some of the PI 3-kinase isoforms activated complexes with p85, loss of Ras activity or a combination of these and perhaps other factors. Decreases in PI(4,5)P 2 by V12 Ras might be less sensitive than p110α to inhibitors such as LY294002 and wortmannin. A novel PI 3-kinase levels due to loss of PI 5-kinase activity occur in detached fibroblasts (McNamee et al., 1993; Chong et al., 1994) , isoform that is~50-fold less sensitive than p110α to wortmannin has been identified recently (Virbasius et al., but not in MDCK cells, so loss of substrate lipid cannot account for the decreases in PI 3-kinase activity. 1996) . It is possible that oncogenic Ras might activate a set of PI 3-kinase isoforms distinct from those activated Since we have shown here that PI 3-kinase is involved in allowing Ras-transformed epithelial cells to survive in by adhesion: if this is so, then specific inhibitors might possibly be developed that could selectively target the the absence of contact with extracellular matrix, inhibitors of this enzyme may have some potential in the treatment Ras-regulated enzymes and target Ras-transformed as opposed to normal cells. of carcinoma. However, the ability of PI 3-kinase inhibitors to induce apoptosis in untransformed cells under normal Several direct and indirect downstream targets for PI 3-kinase have been identified: these include p70 S6K (Chung culture conditions is likely to severely limit any such usage. This may partly explain the considerable toxicity et al., 1994) , novel and atypical protein kinase C isoforms (Nakanishi et al., 1993; Toker et al., 1994) , the Rho family of these agents in whole animals (Gunther et al., 1989) . small GTP-binding protein Rac (Hawkins et al., 1995) adherent MDCK cells, indicating that a constitutive level of activity of PKB/Akt is required for epithelial cell and the serine/threonine kinase PKB/Akt (Burgering and Coffer, 1995; Franke et al., 1995) . Since rapamycin fails survival. PKB/Akt was identified as a retroviral oncogene (Bellacosa et al., 1991) , as well as by its similarity to to induce apoptosis in MDCK cells ( Figure 2D ) and in several other cell types (Yao and Cooper, 1996) , it seems protein kinases A and C (Coffer and Woodgett, 1991; Jones et al., 1991) , and the close relative Akt 2 recently unlikely that p70 S6K is involved in the PI 3-kinase protection from anoikis. From our data, activated Rac does not has been shown to be frequently overexpressed in human ovarian and pancreatic cancers (Bellacosa et al., 1995;  give significant protection from anoikis, thus ruling out this pathway downstream of PI 3-kinase. In other cell Cheng et al., 1996) . PKB/Akt may therefore be able to promote the survival of transformed cells under physiologitypes, protein kinase C isoforms have been implicated in both protection from, and induction of, apoptosis; however, cal conditions and may influence the pathology of many human tumours. in MDCK cells, phorbol esters promote apoptosis (Flach et al., 1995) , making it unlikely that conventional or novel protein kinase C isotypes are able to mediate the protective Materials and methods effect. By contrast, activated PKB/Akt is able to protect MDCK cells substantially from anoikis, so this is likely
Expression vectors
to be the pathway whereby PI 3-kinase influences cell
The Ras expression vectors were generated as described in Marte et al. survival. MDCK cells expressing activated PKB/Akt are (1996) . Activated PI 3-kinase constructs were made by the addition of a carboxy-terminal farnesylation signal from H-Ras to p110 to cause its highly resistant to the apoptosis-inducing effects of PI membrane localization (myc-tagged p110-CAAX in pcDNA3) 3-kinase inhibitors ( Figure 3B ), so PKB/Akt probably (S.Wennström and J.Downward, in preparation). Raf-CAAX and mycrepresents the major pathway by which PI 3-kinase protects tagged Erk2 cDNA were provided by R.Marais and C.J. Marshall (ICR, cells from apoptosis. Dominant-negative mutants of PKB/ London). Gag-PKB cDNA was provided by B.Burgering and P.Coffer (Utrecht). AH-Akt cDNA was provided by Thomas Franke. Akt are able to induce apoptosis when expressed in
Cell lines
Measurement of MAP kinase, PKB/Akt and S6 kinase activation Early passage MDCK cells were provided by J.Taylor-Papadimitriou (ICRF) and were maintained in Dulbecco's modified Eagle's medium Cells were serum starved overnight in DMEM/0.2% FCS and analysed, or detached with trypsin/EDTA, washed once with DMEM/10% FCS (DMEM) supplemented with 10% FCS. To generate stably transfected lines, wild-type cells were transfected with the various constructs by and resuspended in serum-free DMEM. Cells were maintained in suspension for 120 min and analysed or then replated onto collagenlipofection (Lipofectamine, GibcoBRL). Cells were plated at 10 5 /well of a 6-well plate and transfected the following day with 4 μg of DNA coated dishes for varying times. p70 S6K activation was assessed by retardation of electrophoretic mobility due to phosphorylation and by (plus 0.4 μg of a hygromycin resistance plasmid for those vectors not encoding a neomycin resistance gene) and 10 μl of Lipofectamine/well. phosphorylation of substrate peptide (KRRRLASLAA) in immunoprecipitates. MAP kinase activation was measured by immunoprecipitation After 48 h, cells were replated into a 10 cm dish and selected with 250 μg/ml hygromycin or 500 μg/ml G418, as appropriate. Control cells of Erk2 and phosphorylation of myelin basic protein as described (Leevers and Marshall, 1992) . PKB/Akt activity was measured in HA were transfected with empty vector alone or were untransfected. After selection in antibiotic for 10-14 days, individual resistant colonies were tag immunoprecipitates using H2B as a substrate as described (Franke et al., 1995) . Immunoprecipitations and Western blotting protocols were picked and expanded. At least 24 clones were picked for each transfection and expression of protein assessed by Western blotting of cell lysates as described . using appropriate antibodies. Expression of V12 H-Ras and the Ras mutant proteins (C40, G37 and A38) varied between 5-and 10-fold excess over endogenous Ras levels.
